{"id":"W4408144210","doi":"10.1177/22143602241308181","title":"Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension","year":2025,"lang":"en","type":"article","venue":"Journal of Neuromuscular Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Sanofi Genzyme; Grifols; Japan Blood Products Organization; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Biogen; Sanofi; Genentech; AstraZeneca; Amgen","keywords":"Medicine; Adverse effect; Incidence (geometry); Myasthenia gravis; Aseptic meningitis; Internal medicine; Anesthesia; Pediatrics; Meningitis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002862028,0.0002128906,0.0006754914,0.0001655941,0.0001057968,0.00007279996,0.0003395634,0.00004345142,0.000008298533],"category_scores_gemma":[0.0002764074,0.0001216359,0.00008177017,0.0002700696,0.00008785761,0.0002219244,0.0001911745,0.0002585848,2.617884e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003169194,"about_ca_system_score_gemma":0.0001294242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000883966,"about_ca_topic_score_gemma":0.00003699098,"domain_scores_codex":[0.997719,0.0003759716,0.0008469012,0.0003364859,0.0005370543,0.0001846129],"domain_scores_gemma":[0.9984037,0.0001307517,0.000411427,0.0005783986,0.0002591617,0.0002165504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04770402,0.01380498,0.9183804,0.00003767071,0.000364227,0.0007524508,0.0005003225,0.00001826778,0.001721033,0.00001702943,0.00005911513,0.01664043],"study_design_scores_gemma":[0.06944045,0.004411276,0.9242623,0.0006366843,0.0007510221,0.0000180692,0.0001281734,0.00009559689,0.00004918886,0.00006827024,0.00003561135,0.0001033417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997715,0.0007990809,0.00003094679,0.0003645336,0.000087923,0.0008938735,0.0000897367,0.000007351509,0.00001157439],"genre_scores_gemma":[0.9993938,0.00007799047,0.0001280234,0.0002460023,0.00006725211,0.000005151177,0.00004666672,0.0000233669,0.00001175438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02173643,"threshold_uncertainty_score":0.4960169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02406123906191245,"score_gpt":0.3301649406599344,"score_spread":0.306103701598022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}